|
Volumn 60, Issue 5, 2015, Pages 654-658
|
Use of Lactobacillus casei rhamnosus to Prevent Cholangitis in Biliary Atresia After Kasai Operation
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
NEOMYCIN;
PROBIOTIC AGENT;
ADVERSE EFFECTS;
BILIARY ATRESIA;
BODY WEIGHT;
CHOLANGITIS;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
ESCHERICHIA COLI;
FECES;
FEMALE;
HUMAN;
INFANT;
ISOLATION AND PURIFICATION;
LACTOBACILLUS;
LACTOBACILLUS CASEI;
LACTOBACILLUS RHAMNOSUS;
MALE;
MICROBIOLOGY;
NEWBORN;
PILOT STUDY;
PORTOENTEROSTOMY;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
ANTI-BACTERIAL AGENTS;
BILIARY ATRESIA;
BODY WEIGHT;
CHOLANGITIS;
DISEASE-FREE SURVIVAL;
ESCHERICHIA COLI;
FECES;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
LACTOBACILLUS;
LACTOBACILLUS CASEI;
LACTOBACILLUS RHAMNOSUS;
MALE;
NEOMYCIN;
PILOT PROJECTS;
PORTOENTEROSTOMY, HEPATIC;
PROBIOTICS;
RECURRENCE;
|
EID: 85027949873
PISSN: None
EISSN: 15364801
Source Type: Journal
DOI: 10.1097/MPG.0000000000000676 Document Type: Article |
Times cited : (33)
|
References (0)
|